Clinic Hospital Patient Care Radiopharmaceuticals 
Imaging Technology
JUNE 11, 2024
As vice president-elect, my primary goal will be to strengthen SNMMI as a valuable resource for all members, from advancing the field's underlying basic science to providing excellent evidence-based patient care,” stated Jacene. “I An active SNMMI member, Jacene has been involved in many aspects of the organization.
Imaging Technology
JULY 5, 2023
Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
APRIL 2, 2024
“These new capabilities align with our precision care strategy to personalize care, enhance hospital efficiency and clinician effectiveness, and appeal to new and existing GE HealthCare and MIM Software users who see this as an opportunity to better serve patients and help improve outcomes."
Imaging Technology
JUNE 20, 2024
Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system, but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities.
Imaging Technology
JUNE 26, 2023
He performed doctoral and post-doctoral work at Memorial Sloan Kettering Cancer Center and completed his radiology residency at Massachusetts General Hospital. Mahmood has held many volunteer leadership positions throughout the course of his career. Mahmood was also a Highlights lecturer at the SNMMI Annual Meeting.
TTG Imaging Solutions
DECEMBER 26, 2021
We aim to provide the highest quality equipment and service and to deliver value to our customers through turnkey staffing and radiopharmaceutical solutions in our end-to-end model. Sentinel is the right partner to help us grow while maintaining our focus on this goal.”
AuntMinnie
JUNE 3, 2024
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., those interested in expanding care using emerging radioligand therapies (RLTs) may be deciding on how to start or where to expand. We think all of those things are really necessary for optimal patient care."
Expert insights. Personalized for you.
52 
Let's personalize your content